PWRM, Power3 Medical Products, Inc., PWRM.OB
Alzheimer's is one, among the common sort of dementia, an over-all term regarding loss of memory and various other intellectual abilities serious enough to interfere with routine daily life. Alzheimer's condition is the reason for 50 to seventy per cent of dementia cases.
Alzheimer's disease just isn't an everyday aspect of increasing age, although the most significant identified risk factor is increasing age, and the most of individuals with Alzheimer's are 65 and older. Alzheimer's is just not a illness connected with senior years. As much as five percentage of people with the actual condition have early-onset Alzheimer's (also called younger-onset), which frequently appears when someone is in an individual's 40s or 50s.
PWRM is a leading bio-technology company focused on the development of innovative diagnostic tests in the fields of cancer and neurodegenerative diseases such as Alzheimer's disease, Parkinson's disease and amyotrophic lateral sclerosis (commonly known as ALS or Lou Gehrig's disease).
PWRM applies proprietary methodologies to discover and identify protein biomarkers associated with diseases. Through these processes, PWRM has developed a portfolio of products including BC-SeraPro™, a proteomic blood serum test for the early detection of breast cancer for which it has completed Phase I clinical trials, and NuroPro®, a proteomic blood serum test for the detection of neurodegenerative diseases, including Alzheimer's, Parkinson's and ALS diseases, for which it is currently engaged in Phase II clinical trials.
These tests are designed to analyze an individual's proteins to detect the presence of disease, a patient's disease progression, a patient's response to a particular drug, and the mechanisms of disease present in the patient for optimal targeted therapy.
PWRM recently reported that it delivered four poster presentations at the 2010 International Conference on Alzheimer's Disease (NASDAQ:ICAD) in Honolulu, Hawaii. These presentations discussed NuroPro®, PWRM's diagnostic test, and focused on PWRM's Alzheimer's disease blood serum biomarkers, test and clinical validation trials.
More about PWRM at www.Power3Medical.com
ORFG, Orofino Gold Corp., ORFG.PK
Gold's Usefulness as safe haven:
The geo-political and world economic structure is currently undergoing major change-some have even called the situation an "upheaval." This means that the investment outlook, particularly for certain parts of the world, is more unpredictable than usual. Under these circumstances, it is logical to conclude that certain investment portfolios should include real (non-paper) assets such as commodities for protection against a potential decline in the paper markets.
Colombia is Latin America’s fifth largest producer of gold.
ORFG has several Gold development properties in Colombia, a current hot spot of gold production in the world markets.
La Azul is one producing artesanal mine in the Senderos de Oro area controlled by ORFG, it is a mixed sequence of predominantly volcanic rocks with the vien systems comprised of high grade chalcopyrite, galena and sphalerite with pyrite in quartz viens.
According to the company, ORFG will aggressively pursue other known Gold occurrences in the companies Senderos de Oro Gold Camp while the development team works to improve production at La Azul Mine.
More about ORFG at www.orofinogold.com
RC2 Corp. (Nasdaq:RCRC) recently reported the expanded retail availability of its Chuggington Die-Cast toy line in the United States. Inspired by Ludorum's popular train-centric series seen daily in the U.S. on Disney Channel's Playhouse Disney programming block (check local listings), Learning Curve's Chuggington Die-Cast toy line is now available at major retailers. In late 2010, the line made its retail launch in the United States and has been met with enthusiastic consumer response. In holiday 2010, Learning Curve Brands first unveiled the Chuggington Die-Cast toys to incredible consumer demand," said Peter Henseler, President of RC2 / Learning Curve Brands.
RC2 Corporation engages in the design, production, and marketing of toys, collectibles, and infant and toddler products. It offers mother, infant, and toddler category products that include various products related to infant and toddler feeding, gear, care, and play, which are marketed under the brand names of The First Years and Lamaze.
MAP Pharmaceuticals, Inc. (Nasdaq:MAPP) recently reported that the company will present at the 29th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2011 at 8:00 a.m. PT in San Francisco.
MAP Pharmaceuticals, Inc., a development stage company, focuses on the development and commercialization of inhalation therapies for patients suffering from migraine. It is developing LEVADEX, which is in Phase III clinical trials for the treatment of migraine through oral inhalation.
USA Mobility, Inc. (Nasdaq:USMO) recently reported that its Board of Directors has approved a fourth extension of the Company’s share repurchase program from December 31, 2010 to December 30, 2011. In addition, the Board reset the amount available for purchase under the plan from $16.1 million to $25 million as of January 3, 2011. The Company commenced the share repurchase plan in August 2008 to buy back up to $50 million of USA Mobility common stock over a 12-month period. In March 2009 the Board approved an initial supplement to the plan, resetting the amount available for purchase to $25 million, and extending the purchase period. The Board approved a second extension in November 2009 and a third extension in March 2010, at which time it again reset the amount available for purchase to $25 million. Since the program’s inception, the Company has repurchased 5,556,331 shares for approximately $51.7 million.
USA Mobility, Inc. provides wireless messaging solutions to the healthcare, government, large enterprise, and emergency response sectors in the United States. Its one-way messaging consists of numeric messaging services, which enable subscribers to receive messages comprising numbers, such as phone numbers; and alphanumeric messages.
Signup for FREE Daily Stock Alerts From http://www.CRWEFinance.com/signup
THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY!
Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. CRWEFinance.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. Our disclaimer is to be read and fully understood before using our site, reading our newsletter or joining our email list. Release of Liability: Through use of this website viewing or using, you agree to hold CRWEFinance.com report and Crown Equity Holdings Inc. CRWE, its operators, shareholders, employees and/or contractors harmless and to completely release them from any and all liability due to any and all loss (monetary or otherwise), damages (monetary or otherwise) that you may occur. (Read more at http://crwefinance.com/disclaimer) Rule 17B requires disclosure of payment for investor relations. Crown Equity Holdings Inc. (OTCPK:CRWE) is a newswire as well as an IR and PR firm. Crown Equity Holdings Inc. (OTCPK:CRWE), in some cases, provides media advertising and public awareness for both public and private companies, as well as disseminating news. As such, in some cases, when Crown Equity Holdings Inc. (OTCPK:CRWE) advertises for a particular client, Crown Equity Holdings Inc. (OTCPK:CRWE) charges an advertising fee which it must disclose under 17B. The fee may be in cash, in free trading stock or in restricted stock. Crown Equity Holdings Inc. (OTCPK:CRWE), if paid in stock, can and may sell those securities during the advertising period. Crown Equity Holdings Inc. (OTCPK:CRWE) has received 1,000,000 shares 144 restricted stocks for IT department services and 2,000,000 shares (free trade) for 12 months of video production from Power 3 Medical Products Inc. (OTC:PWRM). Crown Equity Holdings Inc. (OTCPK:CRWE) has received 500,000 shares of 144 stock in Orofino Gold Corp. (PINK SHEETS: ORFG) valued at sixty five thousand dollars, and 500,000 shares of free trading shares valued at sixty five thousand dollars from a third party (QU CUI You) for 30 days advertising.